Collaborating for Innovation in Cell Therapy
Emerging technologies play a crucial role in transforming the landscape of cell and gene therapy (CGT). Ori Biotech, a biotechnology firm specializing in CGT, has announced a strategic partnership with Charles River Laboratories (CRL), a well-known contract development and manufacturing organization (CDMO). This collaboration aims to leverage Ori Biotech's innovative IRO platform to enhance the production of CAR-T therapies.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
